EPHB4 and neoplasm: Inhibition of EphB4/ephrinB2, in vitro and in a mouse xenograft model, was associated with an improvement of antitumor responses, particularly when combined with radiotherapy (RT), which resulted in notable reductions in tumor growth in cases of PDAC (145).